<p>隨着年末的臨近，主要的美國股票指數連續三個交易日小幅下跌，反映出市場的持續波動和投資者的謹慎。在這樣的時期，識別有前景的投資機會可能既具挑戰性又富有回報。儘管歷史上有負面含義，便士股票仍然通過突出那些尚未被大型投資者關注的小型或新興公司而提供潛在價值。通過關注那些財務狀況良好且有明確增長路徑的公司，投資者可以在這個常被忽視的市場細分中發現機會。</p>
<h3>美國十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$2.49</td>
<td>$574.34M</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.89</td>
<td>$679.93M</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>WM Technology (MAPS)</td>
<td>$0.8343</td>
<td>$142.68M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.29</td>
<td>$553.59M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.14</td>
<td>$1.29B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.24</td>
<td>$556.91M</td>
<td>✅ 5 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$77.45M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.72</td>
<td>$50.16M</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.98</td>
<td>$7.12M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.97</td>
<td>$89.94M</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們美國便士股票篩選器中的 341 只股票的完整列表。</p>
<p>讓我們更仔細地看看我們從篩選公司中挑選的幾隻股票。</p>
<h2>Cricut (CRCT)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Cricut, Inc. 設計、營銷和分銷一個創意平台，幫助用户在全球各個地區創建專業外觀的手工商品，市值約為 10.6 億美元。</p>
<p><strong>運營：</strong> 公司的收入主要來自其平台部門，產生了 3.2283 億美元的收入。</p>
<p><strong>市值：</strong> 10.6 億美元</p>
<p>Cricut, Inc. 展示了強健的財務狀況，沒有債務，短期資產覆蓋負債良好。最近的收益顯示，2025 年第三季度淨收入增加至 2051 萬美元，較去年增長 30%，超過行業平均水平。儘管股本回報率高達 22.6%，但由於自由現金流覆蓋不足，Cricut 的股息可持續性受到質疑。股票回購表明了股東價值的倡議，而穩定的每週波動性則表明在市場波動中表現一致。然而，過去五年的收益年均下降 24.1%，突顯出潛在的長期挑戰。</p>
<ul>
<li>點擊這裏訪問我們的完整財務健康分析報告，以瞭解 Cricut 的動態。</li>
<li>通過我們的公司收益預估報告，獲取 Cricut 的前景和預期表現的見解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/69398356-a3da-47e9-8ba3-988efc8c2284/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/69398356-a3da-47e9-8ba3-988efc8c2284/chart/financial-position-analysis"/></p>
<p>截至 2025 年 12 月的 CRCT 財務狀況分析</p>
<h2>SOPHiA GENETICS (SOPH)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> SOPHiA GENETICS SA 是一家專注於醫療保健領域的雲原生軟件技術公司，市值為 3.2092 億美元。</p>
<p><strong>運營：</strong> 公司的收入主要來自其醫療保健軟件部門，總計 7330 萬美元。</p>
<p><strong>市值：</strong> 3.2092 億美元</p>
<p>SOPHiA GENETICS，市值為 3.2092 億美元，專注於醫療保健軟件，在便士股票領域中佔有一席之地。儘管處於虧損狀態，並且近年來淨虧損有所增加，但其收入增長速度快於行業平均水平，預計年增長率為 17.6%。最近的合作，如與 Complete Genomics 在精準腫瘤學測試方面的合作，以及與日本的 A.D.A.A.M Innovations 在液體活檢應用方面的合作，突顯了其向新市場的戰略擴展。該公司保持足夠的現金流以覆蓋負債，並且儘管股價波動較大，但最近並未出現顯著的股東稀釋。</p>
<ul>
<li>在這份財務健康報告中解鎖我們對 SOPHiA GENETICS 股票分析的全面見解。</li>
<li>通過我們的詳細增長報告評估 SOPHiA GENETICS 未來的收益預估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/259cc674-c3b8-4e36-b4e3-60d0d9d9b758/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/259cc674-c3b8-4e36-b4e3-60d0d9d9b758/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 12 月的 SOPH 債務與股本歷史及分析</p>
<h2>VTEX (VTEX)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> VTEX 及其子公司為企業品牌和零售商提供軟件即服務的數字商務平台，市值為 6.6099 億美元。</p>
<p><strong>運營：</strong> 該公司從其互聯網軟件與服務部門產生了 2.3412 億美元的收入。</p>
<p><strong>市值：</strong> 6.6099 億美元</p>
<p>VTEX，市值為 6.6099 億美元，在便士股票領域中脱穎而出，保持盈利並從其數字商務平台中產生 2.3412 億美元的年收入。該公司無債務，財務健康良好，短期資產顯著超過負債。儘管最近一次性損失影響了收益，VTEX 的淨收入在 2025 年第三季度從前一年的 337 萬美元增長至 635 萬美元，反映出穩定的增長。最近的戰略舉措包括完成價值 2759 萬美元的股票回購，併為即將到來的季度和 2025 年全年的收入提供樂觀的指導。</p>
<ul>
<li>在我們的財務健康報告中更仔細地看看 VTEX 的潛力。</li>
<li>通過訪問我們的收益增長報告評估 VTEX 的前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9226b21a-fa0f-4ce2-b8a8-0239eb09b3db/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9226b21a-fa0f-4ce2-b8a8-0239eb09b3db/chart/financial-position-analysis"/></p>
<p>截至 2025 年 12 月的 VTEX 財務狀況分析</p>
<h2>將想法轉化為行動</h2>
<ul>
<li>通過我們的篩選器深入瞭解所有 341 只美國便士股票。</li>
<li>想探索一些替代方案嗎？我們發現了 13 只預計明年將支付超過 6% 股息收益率的美國股票。查看完整列表，免費獲取。</li>
</ul>
<p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
<p>國防與災難的移動基礎設施</p>
<p>下一波機器人技術不是類人型的。它是完全自主的塔樓，在 30 分鐘內提供 5G、ISR 和雷達服務，隨時隨地。</p>
<p>在下一輪合同之前獲取投資者簡報</p>
<p>代表 CiTech 贊助</p>

VTEX

CRCT

<p>隨着美國股指面臨下跌，低價股呈現出投資機會。值得關注的股票包括 Cricut、SOPHiA GENETICS 和 VTEX，它們各自擁有強勁的財務狀況和增長潛力。Cricut 的市值為 10.6 億美元，淨收入增長 30%，但面臨長期挑戰。SOPHiA GENETICS 的市值為 3.2092 億美元，雖然尚未盈利，但收入增長迅速。VTEX 的市值為 6.6099 億美元，保持盈利且財務健康，收入指引樂觀。這些股票突顯了儘管整體市場波動，低價股市場的潛力</p>

<p>As the year draws to a close, major U.S. stock indexes have seen slight declines for three consecutive sessions, reflecting ongoing market volatility and investor caution. In such times, identifying promising investment opportunities can be challenging yet rewarding. Penny stocks, despite their historical connotations, continue to offer potential value by highlighting smaller or emerging companies that may not yet be on the radar of larger investors. By focusing on those with strong financials and a clear path to growth, investors can uncover opportunities in this often-overlooked segment of the market.</p>
<div class="lb-trans"><p>隨着年末的臨近，主要的美國股票指數連續三個交易日小幅下跌，反映出市場的持續波動和投資者的謹慎。在這樣的時期，識別有前景的投資機會可能既具挑戰性又富有回報。儘管歷史上有負面含義，便士股票仍然通過突出那些尚未被大型投資者關注的小型或新興公司而提供潛在價值。通過關注那些財務狀況良好且有明確增長路徑的公司，投資者可以在這個常被忽視的市場細分中發現機會。</p>
</div><h3>Top 10 Penny Stocks In The United States</h3>
<div class="lb-trans"><h3>美國十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$2.49</td>
<td>$574.34M</td>
<td>✅ 4 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.89</td>
<td>$679.93M</td>
<td>✅ 4 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>WM Technology (MAPS)</td>
<td>$0.8343</td>
<td>$142.68M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.29</td>
<td>$553.59M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.14</td>
<td>$1.29B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.24</td>
<td>$556.91M</td>
<td>✅ 5 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$77.45M</td>
<td>✅ 2 ⚠️ 5 View Analysis &gt;</td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.72</td>
<td>$50.16M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.98</td>
<td>$7.12M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.97</td>
<td>$89.94M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$2.49</td>
<td>$574.34M</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.89</td>
<td>$679.93M</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>WM Technology (MAPS)</td>
<td>$0.8343</td>
<td>$142.68M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.29</td>
<td>$553.59M</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.14</td>
<td>$1.29B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.24</td>
<td>$556.91M</td>
<td>✅ 5 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$77.45M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.72</td>
<td>$50.16M</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.98</td>
<td>$7.12M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.97</td>
<td>$89.94M</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 341 stocks from our US Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們美國便士股票篩選器中的 341 只股票的完整列表。</p>
</div><p>Let's take a closer look at a couple of our picks from the screened companies.</p>
<div class="lb-trans"><p>讓我們更仔細地看看我們從篩選公司中挑選的幾隻股票。</p>
</div><h2>Cricut (CRCT)</h2>
<div class="lb-trans"><h2>Cricut (CRCT)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Cricut, Inc. designs, markets, and distributes a creativity platform that helps users create professional-looking handmade goods across various regions globally, with a market cap of approximately $1.06 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Cricut, Inc. 設計、營銷和分銷一個創意平台，幫助用户在全球各個地區創建專業外觀的手工商品，市值約為 10.6 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its platform segment, generating $322.83 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自其平台部門，產生了 3.2283 億美元的收入。</p>
</div><p><strong>Market Cap:</strong> $1.06B</p>
<div class="lb-trans"><p><strong>市值：</strong> 10.6 億美元</p>
</div><p>Cricut, Inc. has demonstrated a robust financial standing with no debt and strong short-term asset coverage over liabilities. Recent earnings show an increase in net income to US$20.51 million for Q3 2025, reflecting a significant growth of 30% from the previous year, surpassing industry averages. Despite a high Return on Equity at 22.6%, Cricut's dividend sustainability is questionable due to inadequate free cash flow coverage. Share repurchases indicate shareholder value initiatives, while stable weekly volatility suggests consistent performance amidst market fluctuations. However, past five-year earnings have declined annually by 24.1%, highlighting potential long-term challenges.</p>
<div class="lb-trans"><p>Cricut, Inc. 展示了強健的財務狀況，沒有債務，短期資產覆蓋負債良好。最近的收益顯示，2025 年第三季度淨收入增加至 2051 萬美元，較去年增長 30%，超過行業平均水平。儘管股本回報率高達 22.6%，但由於自由現金流覆蓋不足，Cricut 的股息可持續性受到質疑。股票回購表明了股東價值的倡議，而穩定的每週波動性則表明在市場波動中表現一致。然而，過去五年的收益年均下降 24.1%，突顯出潛在的長期挑戰。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of Cricut.</li>
<li>Gain insights into Cricut's outlook and expected performance with our report on the company's earnings estimates.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏訪問我們的完整財務健康分析報告，以瞭解 Cricut 的動態。</li>
<li>通過我們的公司收益預估報告，獲取 Cricut 的前景和預期表現的見解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/69398356-a3da-47e9-8ba3-988efc8c2284/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/69398356-a3da-47e9-8ba3-988efc8c2284/chart/financial-position-analysis"/></p>
<p>CRCT Financial Position Analysis as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月的 CRCT 財務狀況分析</p>
</div><h2>SOPHiA GENETICS (SOPH)</h2>
<div class="lb-trans"><h2>SOPHiA GENETICS (SOPH)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> SOPHiA GENETICS SA is a cloud-native software technology company focused on the healthcare sector, with a market cap of $320.92 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> SOPHiA GENETICS SA 是一家專注於醫療保健領域的雲原生軟件技術公司，市值為 3.2092 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its healthcare software segment, totaling $73.30 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自其醫療保健軟件部門，總計 7330 萬美元。</p>
</div><p><strong>Market Cap:</strong> $320.92M</p>
<div class="lb-trans"><p><strong>市值：</strong> 3.2092 億美元</p>
</div><p>SOPHiA GENETICS, with a market cap of US$320.92 million, is navigating the penny stock landscape with a focus on healthcare software. Despite being unprofitable and reporting increased net losses over recent years, its revenue is growing faster than the industry average, projected to rise 17.6% annually. Recent collaborations, like those with Complete Genomics for precision oncology testing and A.D.A.A.M Innovations in Japan for liquid biopsy applications, highlight strategic expansions into new markets. The company maintains sufficient cash runway to cover liabilities and has not seen significant shareholder dilution recently despite high share price volatility.</p>
<div class="lb-trans"><p>SOPHiA GENETICS，市值為 3.2092 億美元，專注於醫療保健軟件，在便士股票領域中佔有一席之地。儘管處於虧損狀態，並且近年來淨虧損有所增加，但其收入增長速度快於行業平均水平，預計年增長率為 17.6%。最近的合作，如與 Complete Genomics 在精準腫瘤學測試方面的合作，以及與日本的 A.D.A.A.M Innovations 在液體活檢應用方面的合作，突顯了其向新市場的戰略擴展。該公司保持足夠的現金流以覆蓋負債，並且儘管股價波動較大，但最近並未出現顯著的股東稀釋。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of SOPHiA GENETICS stock in this financial health report.</li>
<li>Assess SOPHiA GENETICS' future earnings estimates with our detailed growth reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這份財務健康報告中解鎖我們對 SOPHiA GENETICS 股票分析的全面見解。</li>
<li>通過我們的詳細增長報告評估 SOPHiA GENETICS 未來的收益預估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/259cc674-c3b8-4e36-b4e3-60d0d9d9b758/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/259cc674-c3b8-4e36-b4e3-60d0d9d9b758/chart/debt-equity-history-analysis"/></p>
<p>SOPH Debt to Equity History and Analysis as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月的 SOPH 債務與股本歷史及分析</p>
</div><h2>VTEX (VTEX)</h2>
<div class="lb-trans"><h2>VTEX (VTEX)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> VTEX, along with its subsidiaries, offers a software-as-a-service digital commerce platform for enterprise brands and retailers, with a market cap of $660.99 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> VTEX 及其子公司為企業品牌和零售商提供軟件即服務的數字商務平台，市值為 6.6099 億美元。</p>
</div><p><strong>Operations:</strong> The company generates $234.12 million in revenue from its Internet Software &amp; Services segment.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司從其互聯網軟件與服務部門產生了 2.3412 億美元的收入。</p>
</div><p><strong>Market Cap:</strong> $660.99M</p>
<div class="lb-trans"><p><strong>市值：</strong> 6.6099 億美元</p>
</div><p>VTEX, with a market cap of US$660.99 million, stands out in the penny stock realm by maintaining profitability and generating US$234.12 million in annual revenue from its digital commerce platform. The company is debt-free and has strong financial health, with short-term assets significantly exceeding liabilities. Despite a recent one-off loss impacting earnings, VTEX's net income grew to US$6.35 million for Q3 2025 from US$3.37 million a year prior, reflecting steady growth. Recent strategic moves include completing a share buyback worth $27.59 million and providing optimistic revenue guidance for the upcoming quarter and full year 2025.</p>
<div class="lb-trans"><p>VTEX，市值為 6.6099 億美元，在便士股票領域中脱穎而出，保持盈利並從其數字商務平台中產生 2.3412 億美元的年收入。該公司無債務，財務健康良好，短期資產顯著超過負債。儘管最近一次性損失影響了收益，VTEX 的淨收入在 2025 年第三季度從前一年的 337 萬美元增長至 635 萬美元，反映出穩定的增長。最近的戰略舉措包括完成價值 2759 萬美元的股票回購，併為即將到來的季度和 2025 年全年的收入提供樂觀的指導。</p>
</div><ul>
<li>Take a closer look at VTEX's potential here in our financial health report.</li>
<li>Evaluate VTEX's prospects by accessing our earnings growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的財務健康報告中更仔細地看看 VTEX 的潛力。</li>
<li>通過訪問我們的收益增長報告評估 VTEX 的前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9226b21a-fa0f-4ce2-b8a8-0239eb09b3db/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/9226b21a-fa0f-4ce2-b8a8-0239eb09b3db/chart/financial-position-analysis"/></p>
<p>VTEX Financial Position Analysis as at Dec 2025</p>
<div class="lb-trans"><p>截至 2025 年 12 月的 VTEX 財務狀況分析</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>將想法轉化為行動</h2>
</div><ul>
<li>Get an in-depth perspective on all 341 US Penny Stocks by using our screener here.</li>
<li>Want To Explore Some Alternatives? We've found 13 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過我們的篩選器深入瞭解所有 341 只美國便士股票。</li>
<li>想探索一些替代方案嗎？我們發現了 13 只預計明年將支付超過 6% 股息收益率的美國股票。查看完整列表，免費獲取。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>國防與災難的移動基礎設施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波機器人技術不是類人型的。它是完全自主的塔樓，在 30 分鐘內提供 5G、ISR 和雷達服務，隨時隨地。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一輪合同之前獲取投資者簡報</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>代表 CiTech 贊助</p>
</div>

3 只市值低於 20 億美元的有潛力的便士股